Posts Tagged: Pharmaceutical


PTAB to determine whether to sanction Kyle Bass for filing IPRs

According to Celgene, the Kyle Bass strategy of shorting a stock and filing an inter partes review challenge is an abuse of the process and not what …
12 days ago 31

What ‘The Economist’ Doesn’t Get About Patents

In what can only be characterized as a bizarre, rambling, and intellectually dishonest article, 'The Economist' has inexplicably taken the position that patents are not necessary for …
17 days ago 35

Hybrigenics gets Orphan Drug designation for the treatment of Acute Myeloid Leukemia

Hybrigenics (ALHYG), a French bio-pharmaceutical company with a focus on research and development of new treatments against proliferative diseases, has announced that the Food and Drug Administration (…
18 days ago 0

The Sticking Point that Shouldn’t Be: The Role of Pharmaceutical Patents in the TPP Negotiations

The controversy swirling around the Trans-Pacific Partnership (TPP) Trade Agreement sheds light on two critically important but divisive issues: international trade and intellectual property protection for pharmaceuticals. …
27 days ago 2

The looming patent nightmare facing the pharmaceutical industry

During the last hearing of the House Judiciary Committee there was an attempt to insert language via amendment that would make it impossible for Kyle Bass and …
2 months ago 17

Refocusing the TPP Debate – IP Rights are Critical to Improving Public Health

To listen to the critics, one would believe that the Trans-Pacific Partnership (TPP) Trade Agreement marks the end of the world for global health, especially for the …
3 months ago 6

Uncle Sam the Patent Troll Sues to Stop Generic HIV Drug

HHS is suing a defendant that merely wants to market a generic version of a drug that is used to treat patients with human immunodeficiency virus (HIV). …
4 months ago 12

Bristol-Myers, AstraZeneca and AmGen maintain strong new drug pipelines

There’s been a lot of positive activity in recent months for Bristol-Myers Squibb of New York City. In early March, the U.S. Food and Drug …
5 months ago 1

Merck, Pfizer and Eli Lilly patenting to stay ahead of patent cliff

The early months of 2015 have been interesting ones for the pharmaceutical industry, an incredibly valuable industry sector that comes under our focus from time to time here …
5 months ago 0

India, Pharmacy to the Developing World, Must Honor IP Rights

Claiming to be the ''Pharmacy to the Developing World'', India argues that their lax intellectual property rights regime is critical to their ability to provide low-cost, quality …
5 months ago 11

Why is the Cystic Fibrosis Foundation under attack for funding the drug of the year?

Cystic fibrosis creates a thick, sticky mucus that builds up in the airways, causing infections, and making it difficult to breathe. Chronic pain is a common problem …
7 months ago 8

Merck seeks patents on cancer treatments, medications for Alzheimer’s

Merck & Co. (NYSE: MRK), which is headquartered in Whitehouse Station, NJ, and also does business under the name Merck Sharp & Dohme MSD, is one of …
7 months ago 0